Also written by Bloomberg News:
Valeant CEO Papa says Drugmaker has 'Turnaround Opportunity of a Lifetime'
x hide permanently

Hedge Fund Can Give Olympus a Clearer Focus

BNN Bloomberg

(Bloomberg Opinion) -- Can you teach an old dog new tricks? Olympus Corp. investors appear willing to bet so. Shares of the camera and medical-device maker, which was mired in a $1.7 billion accounting scandal in 2011, have surged to their highest in almost three years after the Japanese company announced a leadership and board shakeup in response to pressure from U.S. hedge fund ValueAct Capital Management LP...

Mentions: Leadership Opinion Management